Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Other financing activities: 2014-2024

Historic Other financing activities for Zevra Therapeutics (ZVRA) over the last 9 years, with Dec 2024 value amounting to $2.1 million.

  • Zevra Therapeutics' Other financing activities was N/A to -$68,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A change from last year.
  • As of FY2024, Zevra Therapeutics' Other financing activities stood at $2.1 million, which was down 27.42% from $2.9 million recorded in FY2021.
  • In the past 5 years, Zevra Therapeutics' Other financing activities registered a high of $2.9 million during FY2021, and its lowest value of $84,000 during FY2020.
  • Its 1-year average for Other financing activities is $2.1 million, with a median of $2.1 million in 2024.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 72.00% in 2020, then skyrocketed by 3,329.76% in 2021.
  • Over the past 3 years, Zevra Therapeutics' Other financing activities (Yearly) stood at $84,000 in 2020, then surged by 3,329.76% to $2.9 million in 2021, then reached $2.1 million in 2024.